Lenzing AG Initiates Strategic Review of Indonesian Site

Lenzing AG has started a strategic review of its Indonesian production site, considering options such as a potential sale. This aligns with their focus on high-performance fibers with greater margins. The review is expected to lead to impairment losses up to EUR 100 million in 2025, affecting EBIT and net income, though EBITDA remains unchanged.

As part of cost-saving measures, Lenzing plans to cut headcount at its headquarters by 300 jobs, 250 by the end of 2025. These measures aim to save over EUR 25 million annually from 2026, with further savings pushing the total over EUR 45 million by 2027.

Additionally, Lenzing will invest more than EUR 100 million in Austrian sites to enhance competitiveness. The company confirms EBITDA guidance for 2025 and targets EUR 550 million by 2027, assuming market stability.